Prognostic Model for Whole Brain Radiotherapy
Frederik Svendsen from Aarhus University Hospital discusses the challenges of whole brain radiotherapy in patients with brain metastases, highlighting limited survival benefit and risk of overtreatment. In this MEDtalk, he presents validation of a prognostic model based on primary diagnosis, performance status, and systemic disease burden, showing clear survival stratification and supporting better patient selection and shared decision-making in clinical practice.
